Stellar Trading Systems now offers full connectivity to Abaxx Exchange, enabling its global trading clients to access Abaxx’s growing suite of commodity futures contracts directly through Stellar platforms SINGAPORE, Nov. 30, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, together with Stellar Trading Systems Ltd. (“Stellar”), a leading independent software vendor providing front-office execution software to global trading firms, today announced the completion of full connectivity between Stellar’s suite of trading...

Philips Verida spectral CT system, angle viewPhilips Verida spectral CT system, angle viewPhilips Verida spectral CT system, straight-on viewPhilips Verida spectral CT system, straight-on viewNovember 30, 2025Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1] CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4]Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Verida, the world’s first detector-based spectral CT fully powered by AI. This marks a transformative milestone in CT,...

BlueSeal Horizon, industry’s first helium-free 3.0T MRI platformBlueSeal Horizon, industry’s first helium-free 3.0T MRI platformNovember 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at RSNA 2025. A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have significant impact for health providers and patients. 3.0T MRI systems are the most advanced MRI magnet technology in widespread use, providing high-resolution imaging for research...

Company expands portfolio of novel AI-powered clinical and operational solutions delivering proven impact at scale—empowering breakthroughs in care through imaging CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) — DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfolio at RSNA 2025, introducing next-generation imaging informatics and clinical AI solutions. The company is announcing new offerings and major enhancements across its portfolio, spanning disease detection, assessment and monitoring, remote scanning, image management and interpretation, center operations and AI orchestration—all designed to transform the imaging experience and advance population health. “We are entering an era where AI-powered imaging can drive proactive, connected...

MEXICO CITY, Nov. 29, 2025 (GLOBE NEWSWIRE) —  Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America, announed today the successful completion of all inspections and repairs required under the Airworthiness directive issued last Friday by the European Union Aviation Safety Agency (EASA) on the official notification from Airbus (AOT Alert Operators Transmission) affecting approximately 6,000 A320-family aircraft worldwide. The directive addressed a flight-control software issue potentially influenced by solar flares, and in some cases required associated hardware checks. Volaris completed the full scope of work across its fleet without a single flight cancellation and with only...

HOTEL101-MILAN IS SET TO HAVE APPROX. 429 ROOMS TO RISE IN A 1.4 HECTARE PRIME SITE AT SAN DONATO MILANESE, ABOUT A 7-MINUTE DRIVE TO THE MILAN LINATE AIRPORT HOTEL101-MILAN IS EXPECTED TO GENERATE EUR85.8 MILLION IN SALES REVENUE HOTEL101-MILAN IS SET TO BECOME THE SECOND HOTEL101 IN EUROPE, AND WITH ITS 1.4 HECTARE PRIME SITE AND APPROX. 429 ROOMS IS EXPECTED TO BE ONE OF THE TOP 3 LARGEST HOTELS IN THE METROPOLITAN CITY OF MILAN BY ROOMCOUNT(Site location of Hotel101-Milan, Italy set to have approx. 429 rooms) SINGAPORE, Nov. 29, 2025 (GLOBE NEWSWIRE) — Hotel101 Global Holdings Corp. (NASDAQ Ticker: HBNB) (“Hotel101” or “Hotel101 Global”), a leading asset-light, prop-tech hospitality platform pioneering a global standardized “condotel” business model listed on the Nasdaq Stock Exchange and a subsidiary of Philippine-listed...

CHENGDU, China, Nov. 28, 2025 (GLOBE NEWSWIRE) — Maase Inc. (NASDAQ: MAAS) (“MAAS” or the “Company”) today announced the appointment of Mr. Jingkai Li as a director and the chairman of the board of directors (the “Board”), effective November 28, 2025. Mr. Li succeeds Ms. Hong Suong Nguyen, who has resigned from her positions as the chairperson and a director of the Board for personal reasons, effective on the same date. Mr. Li holds an executive master degree in business administration from Macau University of Science and Technology. His appointment reflects the Board’s confidence in his profound management expertise, forward-looking investment vision, and extensive background in the green industry. Over more than a decade leading Guangxi Qinyuan Environmental Protection Co., Ltd., he successfully built a technology-driven, cross-regional...

VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, announces that further to its news release dated June 30, 2025, and in accordance with the terms of a debenture indenture (the “Indenture”) between the Company and Odyssey Trust Company as the debenture trustee (the “Debenture Trustee”) dated May 29, 2023, governing the 12.0% convertible debentures of the Company in the aggregate principal amount of $1,454,000.00 (the “Convertible Debentures“), holders (each, a “Debentureholder“) representing at least 66 2/3% of the outstanding principal of the Convertible Debentures have consented to the extension of the maturity date of the...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces the closing of the second tranche (the “Second Tranche”) of its non-brokered private placement (the “Offering”), previously announced on November 6, 2025, with the first tranche closed on November 14, 2025. Gross proceeds from the Second Tranche totaled CAD $210,000 from the sale of 3,000,000 units (the “Units”) at an issue price of CAD $0.07 per Unit. The Company did not pay any cash finder’s fees pertaining to the Second Tranche of the Offering. The Company will use the proceeds of the Offering towards advancing its Alzheimer’s Disease (“AD”)...

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) today announced an executive transition in which Paul Dale has been appointed President and Chief Operating Officer, effective December 1, 2025, as Calvin LeRoux steps aside from the President role and assumes a one-year appointment as Strategic Advisor to the Chief Executive Officer. Mr. Dale has served as PharmaCorp’s Chief Operating Officer since its inception and will now take on broader leadership responsibilities as PharmaCorp advances its national expansion strategy. “Paul’s appointment reinforces the continuity of our operating model and our confidence in his leadership,” said Alan Simpson, Executive Chairman of PharmaCorp. “His experience managing complex retail organizations and his steady execution...